1. Advisory Committee of the International Autologous Bone Marrow Transplant Registry (1989) Autologous bone marrow transplants: different indications in Europe and America. Lancet ii: 317–318
2. Ash R, Horowitz MM, Gale RP, van Bekkum DW, Casper JY, Gordon-Smith EC, Henslee-Downey PJ, Kolb JH, Lowenberg B, Masaoka T, McGlave PB, Rimm AA, Ringdén O, van Rood JJ, Sondel PM, Vowels Mr, Bortin MM (1991) Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T-cell depletion. Bone Marrow Transplant 7: 443–452
3. Berenson RJ, Bensinger WI, Hill RS, Andrews RG, Garcia-Lopez J, Kalamasz DF, Still BJ, Spitzer G, Buckner CD, Bernstein ID, Thomas ED (1991) Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 77: 1717–1722
4. Bortin MM (1970) A compendium of reported human bone marrow transplants. Transplantation 9: 571–587
5. Bortin MM, Horowitz MM, Rimm AA (1992) Increasing utilization of allogeneic bone marrow transplantation. Results of the 1988–1990 survey. Ann Intern Med 116: 505–512